naphazoline has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Even though the erythroleukemia cell lines K562 and HEL do not express α1-adrenoceptors, some α1-adrenergic drugs influence both survival and differentiation of these cell lines." | 1.37 | α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells. ( Fuchs, R; Haas, HS; Leitinger, G; Letofsky-Papst, I; Sadjak, A; Schauenstein, K; Schraml, E; Stelzer, I, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, R | 2 |
| Schraml, E | 2 |
| Leitinger, G | 2 |
| Stelzer, I | 2 |
| Allard, N | 1 |
| Haas, HS | 2 |
| Schauenstein, K | 2 |
| Sadjak, A | 2 |
| Letofsky-Papst, I | 1 |
2 other studies available for naphazoline and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Apopt | 2011 |
α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells.
Topics: Adrenergic Agents; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Ag | 2011 |